2023
Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities
Kim M, Aseltine R, Tabtabai S. Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities. The American Journal Of Cardiology 2023, 210: 76-84. PMID: 37858595, DOI: 10.1016/j.amjcard.2023.09.086.Peer-Reviewed Original ResearchEffect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure
Mentz R, Anstrom K, Eisenstein E, Sapp S, Greene S, Morgan S, Testani J, Harrington A, Sachdev V, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Adams K, Bhatt K, DeWald T, Axsom K, Murthy S, Rich J, Testani J, Smith B, Vader J, McCulloch M, Skopicki H, Psotka M, Heroux A, Lala-Trindade A, Stevens G, Tang W, Lev Y, William P, Eberly A, Gottleib S, Haught W, Grafton G, Larned J, Tejwani L, Mody F, Krim S, Robinson M, Fang J, Adler A, Bell A, Banerjee D, Ruiz Duque E, Mizyed A, Rommel J, Arhinful J, Goyal P, Hall M, Hummel S, Shetty S, Haas D, Vilaro J, Alexy T, Herre J, Clark J, Ambrosy A, Gaglianello N, Ramasubbu K, Meadows J, Tabtabai S, Sherwood M, Hasni S, D'Urso M, Muneer B, Dunlap S, Davis W, Friedman D, Guglin M, Ferguson A, Abbate A, Smart F. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA 2023, 329: 214-223. PMID: 36648467, PMCID: PMC9857435, DOI: 10.1001/jama.2022.23924.Peer-Reviewed Original ResearchConceptsCause mortalityHeart failureTorsemide groupFurosemide groupTotal hospitalizationsCause hospitalizationEffects of torsemideDiuretic strategyPrespecified subgroupsSecondary outcomesEjection fractionMedian agePrimary outcomeHospitalizationMAIN OUTCOMEPatientsFurosemideMortalityMonthsTorsemidePrimary hypothesisSignificant differencesFinal dateOutcomesTrials
2018
Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease
Yeh D, Schmidt A, Eisman A, Serfas J, Naqvi M, Youniss M, Ryfa A, Khan A, Safi L, Tabtabai S, Bhatt A, Lewis G. Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease. Heart 2018, 104: 2044. PMID: 30030334, DOI: 10.1136/heartjnl-2017-312572.Peer-Reviewed Original ResearchConceptsCardiopulmonary exercise testingRV reserveRight ventricleHeart failureNew York Heart Association classPrimary composite clinical outcomeFirst-pass radionuclide ventriculographyPrevalence of heart failureRV ejection fractionRV systolic functionEvent-free survivalMedian follow-upCongenital heart diseaseReserve groupComposite clinical outcomeAdverse cardiac outcomesTertiary care centreRight ventricular reserveAdverse cardiovascular outcomesPredicting adverse cardiovascular outcomesSystolic function assessmentRV dilatationACHD populationPrognostic impactAsymptomatic patients
2017
Acoustic speech analysis of patients with decompensated heart failure: A pilot study
Murton O, Hillman R, Mehta D, Semigran M, Daher M, Cunningham T, Verkouw K, Tabtabai S, Steiner J, Dec G, Ausiello D. Acoustic speech analysis of patients with decompensated heart failure: A pilot study. The Journal Of The Acoustical Society Of America 2017, 142: el401-el407. PMID: 29092550, PMCID: PMC5724620, DOI: 10.1121/1.5007092.Peer-Reviewed Original ResearchConceptsHeart failureIntracardiac filling pressuresDecompensated heart failureSpeech analysisIndicators of HFAcoustic speech analysisSpeech breathing characteristicsDiuretic treatmentPeripheral edemaPilot studyFilling pressureCreaky voiceSpeech passagesPatientsMonitoring patientsSpeech respirationSpeechIncreasing fundamental frequencyEdemaSustained vowelsAcoustic measurements
2016
National Trends in Hospitalizations of Adults With Tetralogy of Fallot
Schmidt A, Yeh D, Tabtabai S, Kennedy K, Yeh R, Bhatt A. National Trends in Hospitalizations of Adults With Tetralogy of Fallot. The American Journal Of Cardiology 2016, 118: 906-911. PMID: 27530825, PMCID: PMC5349299, DOI: 10.1016/j.amjcard.2016.06.034.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultArrhythmias, CardiacComorbidityCross-Sectional StudiesDatabases, FactualDiabetes MellitusEquipment FailureFemaleHeart FailureHeart Valve Prosthesis ImplantationHospital CostsHospital MortalityHospitalizationHumansHypertensionKidney DiseasesMaleMiddle AgedObesityPneumoniaPrevalencePulmonary ValveTetralogy of FallotUnited StatesYoung AdultConceptsTetralogy of FallotHigher quality of careCo-morbiditiesQuality of careFollow-up of patientsHealth care systemPrevalence of obesityModifiable risk factorsPrevalence of co-morbiditiesRates of co-morbiditiesUnited States Nationwide Inpatient SamplePulmonic valve replacementPrimary admission diagnosisHospitalizations of adultsPopulation of adultsNationwide Inpatient SampleCross-sectional dataCare systemDiagnostic codesValve replacementPrevention effortsHeart failureHospital admissionAdmission diagnosisFollow-up
2015
National Trends in Hospitalizations for Patients With Single-Ventricle Anatomy
Tabtabai S, Yeh D, Stefanescu A, Kennedy K, Yeh R, Bhatt A. National Trends in Hospitalizations for Patients With Single-Ventricle Anatomy. The American Journal Of Cardiology 2015, 116: 773-778. PMID: 26100589, DOI: 10.1016/j.amjcard.2015.05.053.Peer-Reviewed Original ResearchConceptsMedical co-morbiditiesSingle-ventricleHeart failureManagement of HFCo-morbiditiesCost of careSV anatomyAdult hospitalsCohort of patientsNationwide Inpatient SampleLength of stayIncreased cost of careReduce costs of careAnatomy patientsInternational Classification of DiseasesAtrial arrhythmiasCoexisting hypertensionRenal diseaseInhospital mortalityLiver diseaseClassification of DiseasesPatientsImprove outcomesInpatient SampleYounger ageAssessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy
Upadhyay G, Chatterjee N, Kandala J, Friedman D, Park M, Tabtabai S, Hung J, Singh J. Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm 2015, 12: 1201-1208. PMID: 25708879, DOI: 10.1016/j.hrthm.2015.02.022.Peer-Reviewed Original ResearchConceptsCardiac resynchronization therapyDegree of baseline MRMitral regurgitationBaseline MRMR improvementHF hospitalizationClinical outcomesSurface QRSHeart failureAssociated with lower HF hospitalizationsCohort study of patientsImproved ventricular geometryFollow-up echocardiographyPrediction of clinical outcomeReducing mitral regurgitationStudy of patientsAll-cause mortalityPrediction of HFWorsening MRMR severityMedian ageIschemic cardiomyopathyResynchronization therapyImproved survivalMR reduction